Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 69.31 percent increase over losses of $(1.01) per share from the same period last year. The company reported quarterly sales of $1.379 million which beat the analyst consensus estimate of $1.296 million by 6.45 percent. This is a 89.94 percent increase over sales of $726.000 thousand the same period last year.